Full Text View
Tabular View
No Study Results Posted
Related Studies
Symptom Adapted Therapy in GERD Patients (SYMPATHY)
This study has been completed.
Study NCT00343161   Information provided by AstraZeneca
First Received: June 20, 2006   Last Updated: January 11, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Gastroesophageal Reflux
More general conditions related to this trial
Deglutition Disorders
Digestive System Diseases
Esophageal Diseases
Esophageal Motility Disorders
Gastrointestinal Diseases
Interventions listed in this trial
esomeprazole
Additional drug interventions recognized in this trial
Aluminum Hydroxide
Magnesium trisilicate
Omeprazole
More general drug interventions related to this trial
Adjuvants, Immunologic
Antacids
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services